Samuel Constant

2.9k total citations
84 papers, 1.8k citations indexed

About

Samuel Constant is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Organic Chemistry. According to data from OpenAlex, Samuel Constant has authored 84 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 22 papers in Epidemiology and 14 papers in Organic Chemistry. Recurrent topics in Samuel Constant's work include Respiratory viral infections research (22 papers), Inhalation and Respiratory Drug Delivery (18 papers) and Asthma and respiratory diseases (9 papers). Samuel Constant is often cited by papers focused on Respiratory viral infections research (22 papers), Inhalation and Respiratory Drug Delivery (18 papers) and Asthma and respiratory diseases (9 papers). Samuel Constant collaborates with scholars based in Switzerland, France and United States. Samuel Constant's co-authors include Song Huang, Jérôme Lacour, Caroline Tapparel, Laurent Kaiser, Ludovic Wiszniewski, Simone Tortoioli, Valeria Cagno, David Linder, Manel Essaidi-Laziosi and Frédéric Buron and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Samuel Constant

73 papers receiving 1.8k citations

Peers

Countries citing papers authored by Samuel Constant

Since Specialization

Citations

This map shows the geographic impact of Samuel Constant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Constant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Constant more than expected).

Fields of papers citing papers by Samuel Constant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Constant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Constant. The network helps show where Samuel Constant may publish in the future.

Co-authorship network of co-authors of Samuel Constant

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Constant. A scholar is included among the top collaborators of Samuel Constant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Constant. Samuel Constant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An innovative approach for anti-respiratory syncytial virus compound discovery from plant extracts, combining high-throughput screening and metabolomics 2026 ·Biomedicine & Pharmacotherapy ·(unknown), Mathieu Hubert, (unknown), Luis-Manuel Quirós-Guerrero, (unknown), (unknown), (unknown), (unknown), (unknown), Samuel Constant, Song Huang, (unknown), (unknown), Caroline Tapparel, Jean-Luc Wolfender	0
2	Evaluation of a non-animal toolbox informed by adverse outcome pathways for human inhalation safety 2025 ·Frontiers in Toxicology ·Renato Ivan de Ávila, Iris Müller, Helen Barlow, A. Middleton, (unknown), Danilo Basili, (unknown), (unknown), (unknown), (unknown), (unknown), Bernadett Boda, Samuel Constant, Holger Behrsing, Vivek Patel, Maria Teresa Baltazar	0
3	Silicon Carbide Nanowires Impair Mucociliary Clearance-Mediated Innate Immunity in Primary Human Bronchial Epithelial Cells 2025 ·ACS Nano ·(unknown), (unknown), (unknown), Bernadett Boda, Tina Buerki‐Thurnherr, Giacomo Reina, Vera M. Kissling, Samuel Constant, Govind Gupta, Peter Wick	0
4	A Novel In Vitro Primary Human Alveolar Model (AlveolAir™) for H1N1 and SARS-CoV-2 Infection and Antiviral Screening 2025 ·Microorganisms ·Cristiane Lopes, Emilie Laurent, (unknown), Julia Dubois, (unknown), (unknown), Édouard Sage, Bernadett Boda, Song Huang, Manuel Rosa‐Calatrava, Samuel Constant	0
5	Multidrug Combinations against SARS-CoV-2 Using GS-441524 or Ivermectin with Molnupiravir and/or Nirmatrelvir in Reconstituted Human Nasal Airway Epithelia 2024 ·Pharmaceutics ·Denise Siegrist, Hulda R. Jónsdóttir, (unknown), Bernadett Boda, Samuel Constant, Olivier Engler	0
6	Effect of cyclosporin A on respiratory viral replication in fully differentiated ex vivo human airway epithelia 2024 ·Pharmacology Research & Perspectives ·Louise Bondeelle, Song Huang, Samuel Constant, Sophie Clément, Maud Salmona, Jérôme Le Goff, Anne Bergeron, Caroline Tapparel	1
7	Inefficient antiviral response in reconstituted small-airway epithelium from chronic obstructive pulmonary disease patients following human parainfluenza virus type 3 infection 2024 ·Virology Journal ·Louise Bondeelle, Maud Salmona, Véronique Houdouin, Elise Diaz, Jacques Dutrieux, Séverine Mercier‐Delarue, Samuel Constant, Song Huang, Anne Bergeron, Jérôme LeGoff	1
8	Altered cell function and increased replication of rhinoviruses and EV-D68 in airway epithelia of asthma patients 2023 ·Frontiers in Microbiology ·Manel Essaidi-Laziosi, Léna Royston, Bernadett Boda, Francisco Rodríguez, Isabelle Piuz, Nicolas Hulo, Laurent Kaiser, (unknown), Song Huang, Samuel Constant, Caroline Tapparel	3
9	Inactivation of SARS-CoV-2 on salt-coated surfaces: an in vitro study 2023 ·Archives of Microbiology ·(unknown), (unknown), Sandra Weber, (unknown), Samuel Constant, Sandro Steiner, (unknown), Raphaël Pugin, (unknown), (unknown), Manuel C. Peitsch, Julia Hoeng, Adrian Stan	2
10	Antiviral properties of trans-δ-viniferin derivatives against enveloped viruses 2023 ·Biomedicine & Pharmacotherapy ·(unknown), Chiara Medaglia, Robin Huber, (unknown), Laurence Marcourt, Sylvain Schnée, (unknown), Béryl Mazel‐Sanchez, Samuel Constant, Song Huang, Meriem Bekliz, (unknown), Katia Gindro, Emerson Ferreira Queiroz, Caroline Tapparel	14
11	An anti-influenza combined therapy assessed by single cell RNA-sequencing 2022 ·Communications Biology ·Chiara Medaglia, (unknown), (unknown), Yong Zhu, Samuel Constant, Song Huang, Valeria Cagno, Emmanouil T. Dermitzakis, Francesco Stellacci, (unknown), Caroline Tapparel	10
12	Iota-carrageenan extracted from red algae is a potent inhibitor of SARS‐CoV-2 infection in reconstituted human airway epithelia 2021 ·Biochemistry and Biophysics Reports ·David Bovard, Marco van der Toorn, Walter K. Schlage, Samuel Constant, Kasper Renggli, Manuel C. Peitsch, Julia Hoeng	9
13	Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia 2020 ·Cell Reports Medicine ·Andrés Pizzorno, Blandine Padey, Thomas Julien, Sophie Trouillet‐Assant, Aurélien Traversier, Elisabeth Errazuriz-Cerda, (unknown), Julia Dubois, Alexandre Gaymard, François-Xavier Lescure, Victoria Dulière, Pauline Brun, Samuel Constant, Julien Poissy, Bruno Lina, Yazdan Yazdanpanah, Olivier Terrier, Manuel Rosa‐Calatrava	141
14	Multiparametric investigation of non functionalized-AGuIX nanoparticles in 3D human airway epithelium models demonstrates preferential targeting of tumor cells 2020 ·Journal of Nanobiotechnology ·Lucie Sancey, Odile Sabido, Zhiguo Hé, (unknown), Alain Guignandon, (unknown), Jean‐Luc Coll, Michèle Cottier, François Lux, Olivier Tillement, Samuel Constant, Christophe Mas, Delphine Boudard	3
15	Air–Liquid Interface In Vitro Models for Respiratory Toxicology Research: Consensus Workshop and Recommendations 2018 ·PubMed ·Ghislaine Lacroix, Wolfgang Koch, Detlef Ritter, Arno C. Gutleb, Søren Thor Larsen, Thomas Loret, Filippo Zanetti, Samuel Constant, Savvina Chortarea, Barbara Rothen‐Rutishauser, Pieter S. Hiemstra, Emeric Fréjafon, P. Hubert, Laura Gribaldo, Peter Kearns, (unknown), Silvia Diabaté, Carsten Weiß, (unknown), Ingeborg M. Kooter	160
16	Establishment of a Human 3D Tissue-Based Assay for Upper Respiratory Tract Absorption 2018 ·(unknown), Julieta Gradinaru, Lucian Farcal, (unknown), Song Huang, Ludovic Wiszniewski, Nikolaos Parissis, Siegfried Morath, Salvador Fortaner, Thomas Cole, (unknown), Pierre‐Alain Carrupt, Samuel Constant, Sandra Coecke	26
17	A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism 2018 ·PLoS Pathogens ·Eirini D. Tseligka, Komla Sobo, Luc Stoppini, Valeria Cagno, Fabien Abdul, Isabelle Piuz, Pascal Meylan, Song Huang, Samuel Constant, Caroline Tapparel	53
18	The Use of Human 3D Reconstructed Airway Cultures for Tobacco Product Evaluation: Precision Low-Volume Exposures at the Apical Site 2017 ·Holger Behrsing, Song Huang, Samuel Constant	5
19	Feasibility of a 3D human airway epithelial model to study respiratory absorption 2013 ·Toxicology in Vitro ·Astrid Reus, Wilfred Maas, (unknown), Samuel Constant, Yvonne C.M. Staal, (unknown), C. Frieke Kuper	30
20	Comparison of respiratory virus infection between human nasal epithelial cell monolayer and air-liquid interface 3D culture 2011 ·European Respiratory Journal ·Kazuhiro Ito, Song Huang, Samuel Constant	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact